Work

Results of the Afatinib Expanded Access Program (EAP): Efficacy and Safety

Year: 2014

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.08.221

Authors: E.S. Kim, B. Halmos, I.F. Kohut, T. Patel, R.D. Rostorfer, A.I. Spira, A. Cseh, J. McKay, G. Wallenstein, K.F. Mileham

Institutions: Carolinas Healthcare System, Levine Cancer Institute, Columbia University, Abramson Cancer Center, University of Pennsylvania, Mark H. Zangmeister Cancer Center, Orlando Health, Virginia Cancer Specialists, Boehringer Ingelheim (Austria), Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Astellas Pharma

OpenAlex ID: W2098892770

FWCI:

Cites:

Cited by:

Related to: 20